S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.20 (-0.07%)
AAPL   141.56 (+1.79%)
MSFT   226.13 (+0.08%)
FB   275.06 (+0.20%)
GOOGL   1,865.84 (-1.41%)
AMZN   3,283.82 (-0.26%)
TSLA   862.43 (+1.87%)
NVDA   536.72 (-2.15%)
BABA   259.60 (+0.38%)
CGC   32.64 (-3.43%)
GE   10.89 (-1.98%)
MU   79.67 (-3.17%)
AMD   92.86 (+0.08%)
NIO   59.99 (-3.16%)
T   28.78 (-0.52%)
F   11.02 (-4.34%)
ACB   10.16 (-4.60%)
BA   200.61 (-2.54%)
DIS   170.36 (-1.40%)
NFLX   555.03 (-1.79%)
GILD   67.00 (+0.09%)
S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.20 (-0.07%)
AAPL   141.56 (+1.79%)
MSFT   226.13 (+0.08%)
FB   275.06 (+0.20%)
GOOGL   1,865.84 (-1.41%)
AMZN   3,283.82 (-0.26%)
TSLA   862.43 (+1.87%)
NVDA   536.72 (-2.15%)
BABA   259.60 (+0.38%)
CGC   32.64 (-3.43%)
GE   10.89 (-1.98%)
MU   79.67 (-3.17%)
AMD   92.86 (+0.08%)
NIO   59.99 (-3.16%)
T   28.78 (-0.52%)
F   11.02 (-4.34%)
ACB   10.16 (-4.60%)
BA   200.61 (-2.54%)
DIS   170.36 (-1.40%)
NFLX   555.03 (-1.79%)
GILD   67.00 (+0.09%)
S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.20 (-0.07%)
AAPL   141.56 (+1.79%)
MSFT   226.13 (+0.08%)
FB   275.06 (+0.20%)
GOOGL   1,865.84 (-1.41%)
AMZN   3,283.82 (-0.26%)
TSLA   862.43 (+1.87%)
NVDA   536.72 (-2.15%)
BABA   259.60 (+0.38%)
CGC   32.64 (-3.43%)
GE   10.89 (-1.98%)
MU   79.67 (-3.17%)
AMD   92.86 (+0.08%)
NIO   59.99 (-3.16%)
T   28.78 (-0.52%)
F   11.02 (-4.34%)
ACB   10.16 (-4.60%)
BA   200.61 (-2.54%)
DIS   170.36 (-1.40%)
NFLX   555.03 (-1.79%)
GILD   67.00 (+0.09%)
S&P 500   3,832.51 (-0.23%)
DOW   30,837.73 (-0.51%)
QQQ   325.20 (-0.07%)
AAPL   141.56 (+1.79%)
MSFT   226.13 (+0.08%)
FB   275.06 (+0.20%)
GOOGL   1,865.84 (-1.41%)
AMZN   3,283.82 (-0.26%)
TSLA   862.43 (+1.87%)
NVDA   536.72 (-2.15%)
BABA   259.60 (+0.38%)
CGC   32.64 (-3.43%)
GE   10.89 (-1.98%)
MU   79.67 (-3.17%)
AMD   92.86 (+0.08%)
NIO   59.99 (-3.16%)
T   28.78 (-0.52%)
F   11.02 (-4.34%)
ACB   10.16 (-4.60%)
BA   200.61 (-2.54%)
DIS   170.36 (-1.40%)
NFLX   555.03 (-1.79%)
GILD   67.00 (+0.09%)
Log in
NASDAQ:TCDA

Tricida Stock Forecast, Price & News

$7.24
-0.21 (-2.82 %)
(As of 01/25/2021 12:12 PM ET)
Add
Compare
Today's Range
$7.15
Now: $7.24
$7.52
50-Day Range
$6.68
MA: $7.41
$8.12
52-Week Range
$3.74
Now: $7.24
$39.02
Volume8,612 shs
Average Volume434,536 shs
Market Capitalization$363.34 million
P/E RatioN/A
Dividend YieldN/A
Beta1.4
Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). The company has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.
Tricida logo

MarketRank

Overall MarketRank

1.80 out of 5 stars

Medical Sector

133rd out of 1,923 stocks

Pharmaceutical Preparations Industry

66th out of 773 stocks

Analyst Opinion: 3.1Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TCDA
CUSIPN/A
CIKN/A
Phone415-429-7800
Employees157
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$5.32 per share

Profitability

Net Income$-176,810,000.00

Miscellaneous

Market Cap$363.34 million
Next Earnings Date2/25/2021 (Estimated)
OptionableNot Optionable
$7.24
-0.21 (-2.82 %)
(As of 01/25/2021 12:12 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TCDA News and Ratings via Email

Sign-up to receive the latest news and ratings for TCDA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tricida (NASDAQ:TCDA) Frequently Asked Questions

How has Tricida's stock price been impacted by COVID-19 (Coronavirus)?

Tricida's stock was trading at $28.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TCDA shares have decreased by 74.2% and is now trading at $7.24.
View which stocks have been most impacted by COVID-19
.

Is Tricida a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tricida in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Tricida stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TCDA, but not buy additional shares or sell existing shares.
View analyst ratings for Tricida
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Tricida?

Wall Street analysts have given Tricida a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tricida wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Gerrit Klaerner's approval rating as Tricida's CEO?

2 employees have rated Tricida CEO Gerrit Klaerner on Glassdoor.com. Gerrit Klaerner has an approval rating of 100% among Tricida's employees. This puts Gerrit Klaerner in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Tricida's next earnings date?

Tricida is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for Tricida
.

How were Tricida's earnings last quarter?

Tricida, Inc. (NASDAQ:TCDA) released its quarterly earnings results on Monday, November, 9th. The company reported ($1.55) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($1.22) by $0.33.
View Tricida's earnings history
.

What price target have analysts set for TCDA?

4 brokers have issued 12-month target prices for Tricida's stock. Their forecasts range from $8.00 to $40.00. On average, they anticipate Tricida's stock price to reach $19.50 in the next year. This suggests a possible upside of 169.3% from the stock's current price.
View analysts' price targets for Tricida
or view Wall Street analyst' top-rated stocks.

Who are some of Tricida's key competitors?

What other stocks do shareholders of Tricida own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tricida investors own include Pfizer (PFE), Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), Dynavax Technologies (DVAX), VBI Vaccines (VBIV), Aldeyra Therapeutics (ALDX), Atara Biotherapeutics (ATRA), bluebird bio (BLUE), Moderna (MRNA) and AT&T (T).

Who are Tricida's key executives?

Tricida's management team includes the following people:
  • Dr. Gerrit Klaerner, Founder, Pres, CEO & Exec. Director (Age 49, Pay $973.69k)
  • Mr. Geoffrey M. Parker, CFO & Exec. VP (Age 55, Pay $621.02k)
  • Mr. Edward J. Hejlek Esq., J.D., Exec. VP of Intellectual Property (Age 64, Pay $549.83k)
  • Dr. Dawn Parsell Ph.D., Exec. VP of Clinical Devel. (Age 57, Pay $578.62k)
  • Ms. Annie Yoshiyama, VP of Fin. & Chief Accounting Officer (Age 37)
  • Dr. Wilhelm Stahl, Exec. VP & CTO (Age 60)
  • Jackie Cossmon, VP of Investor Relations & Communications
  • Mr. Robert L. McKague J.D., Exec. VP, Company Sec., Gen. Counsel & Chief Compliance Officer
  • Mr. Marc Cobo, Consultant (Age 40)

When did Tricida IPO?

(TCDA) raised $175 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO.

What is Tricida's stock symbol?

Tricida trades on the NASDAQ under the ticker symbol "TCDA."

How do I buy shares of Tricida?

Shares of TCDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tricida's stock price today?

One share of TCDA stock can currently be purchased for approximately $7.24.

How big of a company is Tricida?

Tricida has a market capitalization of $363.34 million. The company earns $-176,810,000.00 in net income (profit) each year or ($3.72) on an earnings per share basis. Tricida employs 157 workers across the globe.

What is Tricida's official website?

The official website for Tricida is www.tricida.com.

How can I contact Tricida?

Tricida's mailing address is 7000 SHORELINE COURT SUITE 201, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-429-7800 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.